Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibodies Regulatory News (FAB)

Share Price Information for Fusion Antibodies (FAB)

Share Price is delayed by 15 minutes
Get Live Data
11.00    -0.50 (-4.35%)
Bid:
10.50
Ask:
11.50
Spread: 1.00 (9.524%)
Market Cap: £13.77m
FAB Live PriceLast checked at - London Stock Exchange

Intraday Fusion Antibodies Share Chart

Net Asset Value(s)

23 Apr 2007 07:01

Fabian Romania Property Fund Ltd23 April 2007 23 April 2007 Fabian Romania Property Fund Limited ("Fabian" or the "Fund") Net Asset Value ("NAV") as at 31 March 2007 Fabian, the AIM listed property fund established to invest in Romanian property,announces that its unaudited NAV per Ordinary Share as at 31 March 2007 was€1.390. This represents an increase of +2.5 per cent. versus the €1.356 reported for 31December 2006. The NAV is calculated in accordance with the Fund's articles of association. The market valuations of the portfolio used within unaudited NAV per OrdinaryShare are: Market Value Bank (Debt)/Cash Other NAV Original InvestmentCascades office €14.7m (€9.4m) €0.3m €5.6m €12.2mBanu office €15.2m (€9.1m) €0.2m €6.3m €12.3mNew Town * €10.0m (€1.2m) €0.9m €9.7m €5.75mLakeview * €8.3m (€5.1m) - €3.2m €5.3mBank Cash - €46.4m - €46.4mOther - - (€0.5m) (€0.5m)Sub-total €48.2m €21.6m €0.9m €70.7m * represents Fabian's share of the development The pipeline to invest the €40m raised on admission to AIM continues to beactively progressed in line with the stated strategy. For further information, please contact: Fabian Romania Property Fund LimitedMark Holdsworth 020 7499 9988 Shore Capital Stockbrokers LimitedDru Danford 020 7408 4090 Deloitte Corporate Finance James Lewis 020 7936 3000 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Jun 20233:34 pmRNSHolding(s) in Company
12th Jun 202311:02 amRNSDirector/PDMR Shareholding
8th Jun 202310:39 amRNSResult of GM and total voting rights
31st May 20235:00 pmRNSTotal Voting Rights
26th May 20234:57 pmRNSHolding(s) in Company
26th May 20231:33 pmRNSHolding(s) in Company
23rd May 20237:00 amRNSResult of Retail Offer and Notice of GM
19th May 202310:01 amRNSREX Retail Offer
19th May 202310:00 amRNSPlacing, Subscription and Retail Offer
3rd Apr 20237:00 amRNSBlock listing Interim Review
31st Mar 20237:00 amRNSChange of Registered Office
21st Mar 20237:00 amRNSPatent application
6th Mar 202311:05 amRNSSecond Price Monitoring Extn
6th Mar 202311:00 amRNSPrice Monitoring Extension
6th Mar 20237:00 amRNSTrading Statement
9th Feb 20237:00 amRNSR&D update: Mammalian Display service
9th Jan 20234:40 pmRNSSecond Price Monitoring Extn
9th Jan 20234:35 pmRNSPrice Monitoring Extension
9th Jan 20232:05 pmRNSSecond Price Monitoring Extn
9th Jan 20232:00 pmRNSPrice Monitoring Extension
9th Jan 202311:05 amRNSSecond Price Monitoring Extn
9th Jan 202311:00 amRNSPrice Monitoring Extension
5th Dec 20227:00 amRNSHalf-year Report
24th Nov 20227:00 amRNSNotice of Results
31st Oct 20221:47 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSBlock admission six monthly return
23rd Sep 202211:44 amRNSResult of AGM
20th Sep 20221:36 pmRNSDirector/PDMR Shareholding
15th Sep 20223:41 pmRNSGrant of options
14th Sep 20222:05 pmRNSSecond Price Monitoring Extn
14th Sep 20222:01 pmRNSPrice Monitoring Extension
6th Sep 20227:00 amRNSGrant of options
1st Sep 20227:00 amRNSNotice of AGM and Director change
23rd Aug 20227:00 amRNSFinal Results
9th Aug 20227:00 amRNSBispecific designs patent application
5th Aug 20224:41 pmRNSSecond Price Monitoring Extn
5th Aug 20224:35 pmRNSPrice Monitoring Extension
28th Jul 20227:00 amRNSAppointment of Chief Executive Officer
6th May 20227:00 amRNSTrading update
1st Apr 20227:00 amRNSBlock admission six monthly return
14th Mar 20227:00 amRNSUpdate on Board changes
28th Feb 20227:00 amRNSDirector changes
22nd Feb 20224:41 pmRNSSecond Price Monitoring Extn
22nd Feb 20224:35 pmRNSPrice Monitoring Extension
21st Feb 20227:00 amRNSDirectorate Change
10th Feb 202212:49 pmRNSStmnt re Share Price Movement
14th Jan 20227:00 amRNSFormation of New Scientific Advisory Panel
11th Jan 20221:26 pmRNSHolding(s) in Company
31st Dec 20217:00 amRNSTotal Voting Rights
16th Dec 20217:00 amRNSExercise of share options and total voting rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.